125 related articles for article (PubMed ID: 36610328)
21. Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.
Satriyo PB; Bamodu OA; Chen JH; Aryandono T; Haryana SM; Yeh CT; Chao TY
J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30691241
[TBL] [Abstract][Full Text] [Related]
22. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
Chen D; Cao G; Liu Q
J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
[TBL] [Abstract][Full Text] [Related]
23. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
[TBL] [Abstract][Full Text] [Related]
25. Subsite-specific metastatic organotropism and risk in gastric cancer: A population-based cohort study of the US SEER database and a Chinese single-institutional registry.
Wang L; Liang B; Jiang Y; Huang G; Tang A; Liu Z; Wang Y; Zhou R; Yang N; Wu J; Shi M; Bin J; Liao Y; Liao W
Cancer Med; 2023 Oct; 12(19):19595-19606. PubMed ID: 37740601
[TBL] [Abstract][Full Text] [Related]
26. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.
Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W
Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029
[TBL] [Abstract][Full Text] [Related]
27. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer.
Baba H; Kanda M; Sawaki K; Umeda S; Miwa T; Shimizu D; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y; Fujii T
Ann Surg Oncol; 2020 Jun; 27(6):2071-2080. PubMed ID: 31659640
[TBL] [Abstract][Full Text] [Related]
28. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
29. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
30. The role of TRPV1 ion channels in the suppression of gastric cancer development.
Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
[TBL] [Abstract][Full Text] [Related]
31. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.
Ru GQ; Wang HJ; Xu WJ; Zhao ZS
Pathol Oncol Res; 2011 Jun; 17(2):341-7. PubMed ID: 21104359
[TBL] [Abstract][Full Text] [Related]
33. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
35. Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer.
Tu L; Xu J; Wang M; Zhao WY; Zhang ZZ; Zhu CC; Tang DF; Zhang YQ; Wang DH; Zuo J; Cao H
Tumour Biol; 2016 Jul; 37(7):8775-82. PubMed ID: 26743780
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
37. A compact VEGF signature associated with distant metastases and poor outcomes.
Hu Z; Fan C; Livasy C; He X; Oh DS; Ewend MG; Carey LA; Subramanian S; West R; Ikpatt F; Olopade OI; van de Rijn M; Perou CM
BMC Med; 2009 Mar; 7():9. PubMed ID: 19291283
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer.
Duan J; Sun L; Huang H; Wu Z; Wang L; Liao W
Mol Med Rep; 2016 Apr; 13(4):3027-35. PubMed ID: 26936091
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
